文献速递冠心病

ISCHEMIA试验中完全血运重建的影响

Impact of Complete Revascularization in the ISCHEMIA Trial.
PubMed 文献 · J Am Coll Cardiol · 2023-07-17

在ISCHEMIA试验中,对无既往搭桥的慢性冠心病患者,侵入性策略组中解剖学完全血运重建(ACR)和功能学完全血运重建(FCR)分别达到43.4%和58.4%。ACR与4年心血管死亡或心肌梗死率降低相关;逆概率加权模型显示,若所有侵入性患者均实现ACR,相比保守管理4年事件率差异为-3.5%(95%CI:-7.2%至0.0%),而总体试验中侵入性减保守的差异为-2.4%。结论提示实现完全血运重建可能改善侵入性策略的结局。

要点

  • 侵入性策略组中ACR和FCR分别有43.4%和58.4%的患者达成。
  • ACR与4年心血管死亡或心梗率降低相关。
  • 若所有侵入性患者实现ACR,4年事件率差异为-3.5%(95%CI:-7.2%至0.0%)。

核心结论

  • 在ISCHEMIA试验中,侵入性策略的结局可能通过实现完全血运重建(尤其是ACR)得到改善。

研究设计与样本

  • ISCHEMIA试验的事后分析,纳入无既往冠状动脉旁路移植术的慢性冠心病患者,随机分为侵入性(INV)或保守(CON)管理。
  • INV组共1,824例患者,ACR和FCR由独立核心实验室评估;逆概率加权模型纳入2,296例INV患者和2,498例CON患者。

主要发现

  • INV组中ACR和FCR分别达到43.4%和58.4%。
  • ACR与不完全血运重建相比,4年心血管死亡或心肌梗死率降低。
  • 逆概率加权模型显示,若所有INV患者实现ACR,相比CON管理4年心血管死亡或心梗率差异为-3.5%(95%CI:-7.2%至0.0%)。
  • 总体ISCHEMIA试验中INV减CON的心血管死亡或心梗事件率差异为-2.4%。
  • FCR结果相似但较弱。

临床怎么用

  • 对于拟行侵入性策略的慢性冠心病患者,应致力于实现完全血运重建,尤其是解剖学完全血运重建,以可能改善预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anatomic complete revascularization (ACR) and functional complete revascularization (FCR) have been associated with reduced death and myocardial infarction (MI) in some prior studies. The impact of complete revascularization (CR) in patients undergoing an invasive (INV) compared with a conservative (CON) management strategy has not been reported. OBJECTIVES: Among patients with chronic coronary disease without prior coronary artery bypass grafting randomized to INV vs CON management in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, we examined the following: 1) the outcomes of ACR and FCR compared with incomplete revascularization; and 2) the potential impact of achieving CR in all INV patients compared with CON management. METHODS: ACR and FCR in the INV group were assessed at an independent core laboratory. Multivariable-adjusted outcomes of CR were examined in INV patients. Inverse probability weighted modeling was then performed to estimate the treatment effect had CR been achieved in all INV patients compared with CON management. RESULTS: ACR and FCR were achieved in 43.4% and 58.4% of 1,824 INV patients. ACR was associated with reduced 4-year rates of cardiovascular death or MI compared with incomplete revascularization. By inverse probability weighted modeling, ACR in all 2,296 INV patients compared with 2,498 CON patients was associated with a lower 4-year rate of cardiovascular death or MI (difference -3.5; 95% CI: -7.2% to 0.0%). In comparison, the event rate difference of cardiovascular death or MI for INV minus CON in the overall ISCHEMIA trial was -2.4%. Results were similar but less pronounced with FCR. CONCLUSIONS: The outcomes of an INV strategy may be improved if CR (especially ACR) is achieved. (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches [ISCHEMIA]; NCT01471522).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Stone GW, Ali ZA, O'Brien SM, et al. Impact of Complete Revascularization in the ISCHEMIA Trial. J Am Coll Cardiol. 2023. PMID: 37462593. doi:10.1016/j.jacc.2023.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。